Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis

Yang Liu,Shuo Liu,Yujun Qin,Lei Zhao,Yiliang Li,Chenghui Zhou,Wei Chen

International Immunopharmacology（2021）

引用 7|浏览3

暂无评分

摘要

•Immune checkpoint inhibitors did not increase the incidence of COVID-19 infection among cancer patients.•Immune checkpoint inhibitors did not increase the mortality of COVID-19 infection among cancer patients.•Immune checkpoint inhibitors may be the better choice for the metastatic cancer patients.

查看译文

关键词

Immune checkpoint inhibitors,Cancer,COVID-19,Meta-analyses

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要